Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, ACC, VEN

Interrodata® raises funding from Fuel Ventures to scale their team to meet demand


Investment enables the company to expand its Analytics-as-a-Service offering, guiding FMCG commercial teams to previously-hidden sales opportunities.

LONDON, June 28, 2023 /PRNewswire/ -- Interrodata®, the UK-based analytics software company, announced today an investment of £2.2m from London-based Fuel Ventures. The funding enables Interrodata to realise its ambition of ridding the FMCG industry of mundane analytics which have historically put the brakes on the commercial performance of many of the world's best-known brands.

Interrodata's proprietary IDAtm platform (Investigative Decision Analytics) automatically makes sense of multiple, complex datasets to bring clarity to sales, marketing and category teams. This enables individuals to outperform their objectives and doubles the pace of brand sales growth. Simple, personalised guidance allows commercial teams at clients like Coca-Cola Europacific Partners and Haleon to move to action fast, based on a common understanding of what's driving performance.

"These days, most enterprise clients are not lacking in data," explains David Boon, Founder and CEO of Interrodata, "yet they have limited human capacity to turn all this data into helpful guidance for their management and lead teams. As a result, teams have had to make-do with dashboards, scorecards or high-level monthly market updates ? or do their own insight discovery manually." Interrodata's innovative software disrupts this ? providing every commercial leader with personalised insight and guidance relevant to their role. This gives them the ability to spend their time on making things happen ? rather than working out what to do. As a result, work becomes more rewarding and leaders can capture sales opportunities that others would miss.

The funding announcement reflects the strong synergy between Interrodata and Fuel Ventures. "Advanced analytics is an attractive market, expected to double in the next 5 years" explained Mark Pearson, Founder & Managing Partner at Fuel Ventures. "But providing personalised insights and relevant guidance at the individual level is a hard problem to solve. Interrodata have something unique ? the encoding of deep industry expertise to their analytic platform, so that it yields helpful guidance for each manager. That's what enables them to deliver such a strong ROI for their enterprise clients."

"With demand for our service greater than ever, I'm thrilled to be able to grow the team so that we can serve more clients. Together with our clients we will build strong resilient brands, more exciting careers and new efficiencies in ways of working." concludes David.

About Interrodata

Interrodata is a pioneering software-as-a-service company specialising in AI-powered investigative analysis and storytelling. Blending deep FMCG and Retail experience with enterprise-grade software expertise, Interrodata serve global clients from a UK base. Interrodata works with clients who are data-rich but insight-poor to help them to discover, prioritise and unlock revenue growth opportunities. Interrodata are the experts behind IDATM, the Investigative Decision Analytics platform - a user-friendly insights assistant that allows commercial and marketing teams (whatever their data and analytic skills) to discover the patterns that really matter in their data and guide them to action. IDA saves organisations up to 90% of their analytics time, enabling clients to lead the thinking and action that drives value.

About Fuel Ventures

Fuel Ventures is one of the most active early and growth stage investors in the UK into leading fast growth technology businesses. The Fuel Ventures Fund invest in the most ambitious entrepreneurs in the sectors covering globally scalable marketplaces, platforms and software (SaaS).

Fuel invest in companies at an early stage and work closely with the founders providing hands-on support and a collaborative ecosystem.

Photo: https://mma.prnewswire.com/media/2142536/Mark_Pearson.jpg
Photo: https://mma.prnewswire.com/media/2142537/David_Boon.jpg


These press releases may also interest you

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:44
Alerian MLP ETF (the "Fund" or "AMLP") has modified the estimate of the Fund's deferred tax liability based on information reported by the Master Limited Partnerships (MLPs) and recorded an additional tax accrual of approximately $32.1 million...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 20:00
Chainstack, a frontrunner among the top three global Web3 infrastructure providers, has successfully secured a strategic investment from SBI Ven Capital, Sygnum, Azimut Group, Unicorn Factory Ventures, and Ventech Ventures. This investment will...



News published on and distributed by: